EUVIMEDEUVIMED entdecken
Crossref

Association Between Circulating Immunobiomarkers and Survival In Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiation (CRT): Longitudinal Analyses from NRG-RTOG 0617

J.A. Miccio, C. Hu, T. Schell, J.D. Bradley, W. Wang, J.Y. Jin, G.H. Perdew, B. Lu, F. Dong, L. Beidler, R. Jordan, S. DeVries und 7 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S83

DOI: 10.1016/j.ijrobp.2026.06.095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J.A. Miccio und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Miccio, J., Hu, C., Schell, T., Bradley, J., Wang, W., Jin, J., Perdew, G., Lu, B., Dong, F., Beidler, L., Jordan, R., DeVries, S., Werner-Wasik, M., Garces, Y., Narayan, S., Robinson, C., Lyness, J., Kong, F., & Machtay, M. (2026). Association Between Circulating Immunobiomarkers and Survival In Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiation (CRT): Longitudinal Analyses from NRG-RTOG 0617. International Journal of Radiation Oncology*Biology*Physics, 126(1), S83. https://doi.org/10.1016/j.ijrobp.2026.06.095

Vancouver

Miccio J, Hu C, Schell T, Bradley J, Wang W, Jin J, et al. Association Between Circulating Immunobiomarkers and Survival In Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiation (CRT): Longitudinal Analyses from NRG-RTOG 0617. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S83. doi:10.1016/j.ijrobp.2026.06.095

BibTeX
@article{Miccio2026,
  author = {Miccio, J.A. and Hu, C. and Schell, T. and Bradley, J.D. and Wang, W. and Jin, J.Y. and Perdew, G.H. and Lu, B. and Dong, F. and Beidler, L. and Jordan, R. and DeVries, S. and Werner-Wasik, M. and Garces, Y. and Narayan, S. and Robinson, C.G. and Lyness, J. and Kong, F.M. and Machtay, M.},
  title = {Association Between Circulating Immunobiomarkers and Survival In Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiation (CRT): Longitudinal Analyses from NRG-RTOG 0617},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S83},
  doi = {10.1016/j.ijrobp.2026.06.095}
}
Kostenlos starten →